The Pharmaceutical Market: Italy

Date: January 31, 2013
Pages: 76
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P8CB0C9937FEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Italy
OVERVIEW OF THE PHARMACEUTICAL MARKET IN ITALY

The sharp drop in public pharmaceutical expenditure in Italy in the first four months of 2012 serves as a warning for the continuation of a fall in spending on medicinesduringthe remainder of the year. BMInotes that this does not bode well for drug makers selling their products in Italy as the success of the implemented policies may encourage the enforcement of further cost-containment measures, which,together with the ongoing public hospital debt situation, seriously hampers the country's attractiveness as a location in which to sell drugs, despite its favourable demographic characteristics.

Headline Expenditure Projections

Pharmaceuticals: EUR24.90bn (US$34.63bn) in 2011 to EUR23.54bn (US$29.89bn) in 2012;
-5.5% in local currency terms (-13.7% in US dollar terms).

Healthcare: EUR152.17bn (US$211.63bn) in 2011 to EUR155. 52bn (US$197.51bn) in 2012; +2.2% growth in local currency terms (-6.7% in US dollar terms).

Medical devices: EUR6.42bn (US$8.93bn) in 2011 to EUR6.61bn (US$8.40bn) in 2012; +3.0% growth in local currency terms (-5.9% in US dollar terms).

Risk/Reward Rating: In our Pharmaceuticals and Healthcare Risk/Reward Ratings (RRRs) for Q113, Italy is ninth out of the 10 markets surveyed in Western Europe. Despite being a large market, Italy is characterised by low levels of annual growth, largely because of widespread price cuts. Additionally, the Italian economy is one of the most vulnerable economies in an already shaky eurozone. High levels of public debt, poor infrastructure and a lack of competitiveness indicate that the country will remain one of the region's laggards over the forecast period.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

      Italy Pharmaceuticals And Healthcare Industry SWOT
      Italy Political SWOT
      Italy Economic SWOT
      Italy Business Environment SWOT

PHARMACEUTICALS RISK/REWARD RATINGS

      Table: Western Europe Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113
      Rewards
      Risks

ITALY – MARKET SUMMARY

REGULATORY REGIME

      Intellectual Property Developments
      Pricing Regime
      Reimbursement Regime

INDUSTRY DEVELOPMENTS

      Epidemiology
      Healthcare Sector
      Biotechnology
      Clinical Trials
      Medical Devices

INDUSTRY FORECAST SCENARIO

   Overall Market Forecast
      Table: Pharmaceutical Sales Indicators 2008-2016
   Key Growth Drivers – Industry
      Table: Healthcare Expenditure Indicators 2008-2016
   Key Growth Drivers – Macroeconomic
      Table: Italy – GDP By Expenditure, Current Prices Breakdown
   Prescription Drug Market Forecast
      Table: Prescription Drug Sales Indicators 2008-2016
   Patented Drug Market Forecast
      Table: Patented Drug Market Indicators 2008-2016
   Generic Drug Market Forecast
      Table: Generic Drug Sales Indicators 2008-2016
   OTC Medicine Market Forecast
      Table: OTC Medicine Sales Indicators 2008-2016
   Medical Device Market Forecast
   Pharmaceutical Trade Forecast
      Table: Exports and Imports Indicators 2008-2016
   Other Healthcare Data Forecasts
   Key Risk To BMI’s Forecasts

COMPETITIVE LANDSCAPE

      Pharmaceutical Industry

© BUSINESS MONITOR INTERNATIONAL LTDPAGE

Italy Pharmaceuticals & Healthcare Report Q1 2013
      Recent Company Developments
      Pharmaceutical Wholesale Sector
      Retail Pharmacy Sector

COMPANY PROFILES

  Local Companies
      Recordati
      Menarini
  Multinational Companies
      GlaxoSmithKline
      Pfizer
      Novartis
      Sanofi
      Merck & Co

DEMOGRAPHIC OUTLOOK

      Table: Italy’s Population By Age Group, 1990-2020 (‘000)
      Table: Italy’s Population By Age Group, 1990-2020 (% of total)
      Table: Italy’s Key Population Ratios, 1990-2020
      Table: Italy’s Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

  How We Generate Our Pharmaceutical Industry Forecasts
      Pharmaceutical Risk/Reward Ratings Methodology
      Ratings Overview
      Table: Pharmaceutical Risk/Reward Indicators
      Weighting
      Table: Weighting Of Components
      Sources
Skip to top


The Pharmaceutical Market: Japan US$ 1,295.00 Jan, 2013 · 99 pages
The Pharmaceutical Market: Jordan US$ 1,295.00 Jan, 2013 · 112 pages

Ask Your Question

The Pharmaceutical Market: Italy
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: